Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-026296
Filing Date
2016-06-09
Accepted
2016-06-09 16:27:32
Documents
1
Period of Report
2016-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5649
  Complete submission text file 0001179110-16-026296.txt   7246
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O PDI INC SADDLE RIVER EXEC CENTRE, 1 RT 17 SOUTH SADDLE RIVER NJ 07458
Business Address
ELLBERGER LARRY (Reporting) CIK: 0001219551 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15006 | Film No.: 161706278